Page last updated: 2024-08-18

pyrazolanthrone and Local Neoplasm Recurrence

pyrazolanthrone has been researched along with Local Neoplasm Recurrence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
André, F; Bianchini, G; Bottai, G; de Thè, H; Desmedt, C; Di Leo, A; Győrffy, B; Hortobagyi, GN; Iwamoto, T; Kéri, G; Lehmann-Che, J; Orfi, L; Pusztai, L; Santarpia, L; Sotiriou, C; Turner, NC	1

Other Studies

1 other study(ies) available for pyrazolanthrone and Local Neoplasm Recurrence

Article	Year
TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers. Molecular oncology, 2014, Volume: 8, Issue:3 Topics: Anthracenes; Breast; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Female; Genes, p53; Humans; Mutation; Neoplasm Recurrence, Local; Prognosis; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Survival Analysis; Tumor Suppressor Protein p53	2014

Article

Year

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.

Molecular oncology, 2014, Volume: 8, Issue:3

Topics: Anthracenes; Breast; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Female; Genes, p53; Humans; Mutation; Neoplasm Recurrence, Local; Prognosis; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Survival Analysis; Tumor Suppressor Protein p53

2014